| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2017 | ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis | Chiu K.-L.; Lin Y.-S.; Kuo T.-T.; Lo C.-C.; Huang Y.-K.; Chang H.-F.; Chuang E.Y.; Lin C.-C.; Cheng W.-C.; Liu Y.-N.; LIANG-CHUAN LAI ; Sher Y.-P. | Oncotarget | 9 | 11 | |
| 2016 | Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infections | Chi C.-Y.; Lin C.-H.; Ho M.-W.; Ding J.-Y.; Huang W.-C.; Shih H.-P.; Yeh C.-F.; Fung C.-P.; HSIN-YUN SUN ; Huang C.-T.; Wu T.-S.; Chang C.-Y.; Liu Y.-M.; Feng J.-Y.; Wu W.-K.; Wang L.-S.; Tsai C.-H.; Ho C.-M.; Lin H.-S.; Chen H.-J.; Lin P.-C.; Liao W.-C.; Chen W.-T.; Lo C.-C.; Wang S.-Y.; Kuo C.-Y.; Lee C.-H.; Ku C.-L. | Medicine (United States) | 43 | ||
| 2018 | Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan | CHEN-HUA LIU ; Yu M.-L.; Peng C.-Y.; Hsieh T.-Y.; Huang Y.-H.; Su W.-W.; Cheng P.-N.; Lin C.-L.; Lo C.-C.; Chen C.-Y.; Chen J.-J.; Ma Q.; Brooks-Rooney C.; Kao J.-H. | Alimentary Pharmacology and Therapeutics | 19 | ||
| 2020 | Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH) | Huang C.-F.; Lai H.-C.; Chen C.-Y.; Tseng K.-C.; Kuo H.-T.; Hung C.-H.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; Kao J.-H.; Liu C.-J.; CHEN-HUA LIU ; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; Yu M.-L. | The American journal of gastroenterology | 0 | ||
| 2016 | Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer | MEI-HWEI CHANG ; You S.-L.; Chen C.-J.; Liu C.-J.; Lai M.-W.; Wu T.-C.; Wu S.-F.; Lee C.-M.; Yang S.-S.; Chu H.-C.; Wang T.-E.; Chen B.-W.; Chuang W.-L.; Soon M.-S.; Lin C.-Y.; Chiou S.-T.; Kuo H.-S.; Chen D.-S.; Yang Y.-J.; Lo G.-H.; Kong M.-S.; Wang P.-M.; Yang C.-C.; Chu C.-H.; Lin L.-H.; Chien R.-N.; Lee T.-H.; Yang K.-C.; Liao L.-Y.; Mo L.-R.; Liu J.-D.; Yang T.-H.; Lo C.-C.; Tsai M.-H.; Chou C.-H.; Cheng Y.-S. | Gastroenterology | 78 | ||
| 2012 | Organizational learning differences in healthcare services: The case of medical centres in Taiwan | Luh Y.-H.; Huang F.-M.; Chien Y.-N.; Lo C.-C.; YIR-HUEIH LUH | Applied Economics | 0 | 0 | |
| 2019 | Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study | CHEN-HUA LIU ; Yu M.-L.; Peng C.-Y.; Hsieh T.-Y.; Huang Y.-H.; Su W.-W.; Cheng P.-N.; Lin C.-L.; Lo C.-C.; Chen C.-Y.; Chen J.-J.; Ma Q.; Brooks-Rooney C.; Kao J.-H. | Journal of the Formosan Medical Association | 7 | ||
| 2020 | Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis | Hsu W.-F.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; Kao J.-H.; Liu C.-J.; CHEN-HUA LIU ; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Tsai P.-C.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y. | Scientific Reports | 1 |
